Filing Details

Accession Number:
0001104659-25-035507
Form Type:
13G Filing
Publication Date:
2025-04-15 20:00:00
Filed By:
AMTRUST FINANCIAL SERVICES, INC.
Company:
180 Life Sciences Corp. (NASDAQ:ATNF)
Filing Date:
2025-04-16
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
AMTRUST FINANCIAL SERVICES, INC. 0 509,707 9.8%
AMTRUST INTERNATIONAL UNDERWRITERS DAC 0 509,707 9.8%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
AMTRUST FINANCIAL SERVICES, INC.
 
Signature:/s/ Stephen Ungar
Name/Title:Executive Vice President, General Counsel
Date:04/16/2025
 
AMTRUST INTERNATIONAL UNDERWRITERS DAC
 
Signature:/s/ Peter Farrell
Name/Title:Company Director
Date:04/16/2025
Exhibit Information

99.1 - Joint Filing Agreement